Arcutis Biotherapeutics, Inc.
ARQT
$20.69
-$0.55-2.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 224.00M | 220.98M | 191.07M | 190.82M | 198.09M |
| Total Receivables | 144.38M | 146.23M | 115.12M | 106.69M | 85.42M |
| Inventory | 37.39M | 22.63M | 22.42M | 16.32M | 16.61M |
| Prepaid Expenses | 16.29M | 11.59M | 11.05M | 8.68M | 16.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.00M | 9.79M | 9.57M | 10.27M | 7.54M |
| Total Current Assets | 438.06M | 411.23M | 349.22M | 332.78M | 323.67M |
|
|
|||||
| Total Current Assets | 438.06M | 411.23M | 349.22M | 332.78M | 323.67M |
| Net Property, Plant & Equipment | 5.40M | 5.51M | 5.78M | 3.12M | 3.34M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 14.25M | 14.81M | 15.38M | 15.94M | 16.50M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.30M | 1.42M | 596.00K | 596.00K | 596.00K |
| Total Assets | 460.00M | 432.97M | 370.98M | 352.43M | 344.11M |
|
|
|||||
| Total Accounts Payable | 18.30M | 12.53M | 5.80M | 15.08M | 24.53M |
| Total Accrued Expenses | 136.96M | 116.02M | 92.98M | 87.85M | 65.76M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.95M | 1.29M | 1.00M | 1.00M | 842.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 163.20M | 129.84M | 99.77M | 103.94M | 91.13M |
|
|
|||||
| Total Current Liabilities | 163.20M | 129.84M | 99.77M | 103.94M | 91.13M |
| Long-Term Debt | 101.47M | 107.96M | 107.50M | 107.05M | 107.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.25M | 5.27M | 5.28M | 2.11M | 2.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 431.00K | 431.00K | 360.00K | 360.00K | 360.00K |
| Total Liabilities | 270.36M | 243.49M | 212.90M | 213.46M | 201.45M |
|
|
|||||
| Common Stock & APIC | 1.34B | 1.33B | 1.31B | 1.30B | 1.29B |
| Retained Earnings | -1.15B | -1.14B | -1.16B | -1.16B | -1.15B |
| Treasury Stock & Other | -514.00K | -44.00K | -62.00K | -35.00K | -140.00K |
| Total Common Equity | 189.65M | 189.48M | 158.07M | 138.97M | 142.66M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 189.65M | 189.48M | 158.07M | 138.97M | 142.66M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 189.65M | 189.48M | 158.07M | 138.97M | 142.66M |
|
|
|||||